Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Aurélien, Lebreton"'
Autor:
Sylvain Lamoine, Vincent Jury, Virginie Fourneyron, Jonathan Douxfils, Dorian Teissandier, Laurie Talon, Thomas Sinegre, Aurélien Lebreton
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102576- (2024)
Background: The incidence of cardiovascular diseases is increasing in persons with hemophilia A (HA). Therefore, anticoagulant therapy based on direct oral anticoagulants (DOACs) may be needed, despite the bleeding risk. In case of surgery or bleedin
Externí odkaz:
https://doaj.org/article/cd2213ce0bf847a7b9aadd36b2934e9d
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Anti-factor Xa assays and activated partial thromboplastin time (aPTT) are mainly employed to monitor patients treated with heparins. According to the Clinical and Laboratory Standards Institute and the French Working Group on Hae
Externí odkaz:
https://doaj.org/article/604eef83f50949788af993219f4ceef7
Autor:
Ngoc Anh Thu Nguyen, Pascal Auquier, Any Beltran Anzola, Roseline D’oiron, Thierry Lambert, Céline Falaise, Christine Biron, Anne Lienhart, Jenny Goudemand, Antoine Rauch, Bénédicte Wibaut, Sabine Marie Castet, Dominique Desprez, Annie Harroche, Natalie Stieltjes, Annie Borel-Derlon, Marc Trossaërt, Amandine Celli, Benoît Guillet, Sophie Bayart, Marie-Anne Bertrand, Alexandra Fournel, Guillaume Mourey, Valérie Gay, Pierre Chamouni, Emmanuelle DE Raucourt, Birgit Frotscher, Michèle Martin, Mathieu Puyade, Brigitte Tardy, Stéphane Vanderbecken, Fabienne Genre-Volot, Philippe Nguyen, Benoît Polack, Caroline Oudot-Challard, Stéphane Girault, Annelise Voyer, Aurélien Lebreton, Abel Hassoun, Philippe Moreau, Pierre-Simon Rohrlich, Karine Baumstarck, Mohamed Boucekine, Vanessa Milien, Natacha Rosso, Clemence Tabele, Marie Viprey, Nicolas Giraud, Thomas Sannie, Hervé Chambost, Noémie Resseguier
Publikováno v:
HemaSphere, Vol 7, p e623777c (2023)
Externí odkaz:
https://doaj.org/article/35f0ccb00974432f92e9847dd92e5503
Autor:
Laurie Talon, Virginie Fourneyron, Alexandre Trapani, Bruno Pereira, Thomas Sinegre, Aurélien Lebreton
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Abstract Background The routine D‐dimer quantification to exclude venous thromboembolism has led to the development of many assays, the usefulness of which depends on their reliability and performance. Objective We evaluated the analytical performa
Externí odkaz:
https://doaj.org/article/e82e76e578504f0fb58181bad55b7a25
Autor:
Laure Morimont, Marie Didembourg, Hélène Haguet, Élise Modaffari, Maxence Tillier, Céline Bouvy, Aurélien Lebreton, Jean‐Michel Dogné, Jonathan Douxfils
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 7, Pp n/a-n/a (2021)
Abstract Background and objective Although the endogenous thrombin potential (ETP)‐based activated protein C (APC) resistance is recommended for the development of steroid contraceptive agents, one of the main limitations of this technique was its
Externí odkaz:
https://doaj.org/article/6f6c0c8e38c345fcb29951359cce23f9
Autor:
Thomas Sinegre, Cédric Duron, Thomas Lecompte, Géraldine Lamblin, Laurie Talon, Léon Muti, Sylvie Massoulier, Bruno Pereira, Aurélien Lebreton, Armand Abergel
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1441-1452
Autor:
Vincent Demolombe, Alexandre G. de Brevern, Liza Felicori, Christophe NGuyen, Ricardo Andrez Machado de Avila, Lionel Valera, Bénédicte Jardin-Watelet, Géraldine Lavigne, Aurélien Lebreton, Franck Molina, Violaine Moreau
Publikováno v:
BMC Bioinformatics, Vol 20, Iss 1, Pp 1-14 (2019)
Abstract Background Bioinformatics methods are helpful to identify new molecules for diagnostic or therapeutic applications. For example, the use of peptides capable of mimicking binding sites has several benefits in replacing a protein which is diff
Externí odkaz:
https://doaj.org/article/ff515995205d4f2abb939e660c9c70f5
Autor:
Nicolas Gendron, Richard Chocron, Paul Billoir, Julien Brunier, Laurence Camoin-Jau, Marie Tuffigo, Dorothée Faille, Dorian Teissandier, Juliette Gay, Emmanuelle de Raucourt, Ludovic Suner, Corentin Bonnet, Anne-Céline Martin, Dominique Lasne, Chayma Ladhari, Aurélien Lebreton, Laurent Bertoletti, Nadine Ajzenberg, Pascale Gaussem, Pierre-Emmanuel Morange, Véronique Le Cam Duchez, Alain Viallon, Pierre-Marie Roy, Agnès Lillo-le Louët, David M. Smadja
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Idarucizumab has been included in guidelines for the management of bleeding or surgical procedure in dabigatran-treated patients without need for biological monitoring. The aim of the study was to assess the prognostic value of dabigatran
Externí odkaz:
https://doaj.org/article/77b2e91034cd4ed4ace3d0c00147b6e3
Autor:
Justine Hugon-Rodin, Camille Carrière, Ségolène Claeyssens, Nathalie Trillot, Nicolas Drillaud, Christine Biron-Andreani, Cécile Lavenu-Bombled, Anna Wieland, Claire Flaujac, Natalie Stieltjes, Aurélien Lebreton, Thomas Brungs, Andrea Hegglin, Mathieu Fiore, Céline Desconclois, Valérie Gay, Brigitte Tardy-Poncet, Philippe Beurrier, Virginie Barbay, Pierre Chamouni, Emmanuel De Maistre, Tomas Simurda, Alessandro Casini
BACKGROUND Women with hereditary fibrinogen disorders (HFDs) seem to be at increased risk of adverse obstetrical outcomes, but epidemiologic data are limited Patients/methods: We conducted a retrospective and prospective international study to determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0f4e913709c7a5ad5af681f0553bf4
Autor:
Jean-Michel Dogné, Aurélien Lebreton, Thomas Lecompte, Yves Gruel, Charlotte Cordonnier, Robert C. Gosselin, Pierre Sié, Jonathan Douxfils, Caroline Vayne, Gilles Pernod, Sophie Susen, Philippe Nguyen, Julien Favresse, François Mullier
Publikováno v:
Thrombosis Research
Thrombosis research, Vol. 203, p. 163-171 (2021)
Thrombosis research, Vol. 203, p. 163-171 (2021)
As of 4 April 2021, a total of 169 cases of cerebral venous sinus thrombosis (CVST) and 53 cases of splanchnic vein thrombosis were reported to EudraVigilance among around 34 million people vaccinated in the European Economic Area and United Kingdom